Andrey Loboda

8PUBLICATIONS
96CO-AUTHORS
Predictive and prognostic markersCancer cell biologyTumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 01, 2025
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial.

Brian I Rini, Elizabeth R Plimack, Viktor Stus

|Mar 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies.

Yelena Y Janjigian, Michael Cecchini, Kohei Shitara

|Dec 10, 2024
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer.

Ramani Soundararajan, Michelle M Maurin, Jetsen Rodriguez-Silva

|Feb 09, 2024
Single-Cell Analysis Identifies NOTCH3-Mediated Interactions between Stromal Cells That Promote Microenvironment Remodeling and Invasion in Lung Adenocarcinoma.

Handan Xiang, Yidan Pan, Marc A Sze

|Mar 05, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.

Joaquim Bellmunt, Ronald de Wit, Yves Fradet

|Dec 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models.

Peter Georgiev, Eric S Muise, Douglas E Linn

Pageof 2

Frequent Collaborators

4 joint publications

Razvan Cristescu

2 joint publications

Amir Vajdi

2 joint publications

Elizabeth R Plimack

2 joint publications

Jeeyun Lee